(Q42882348)

English

EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors

scientific article published on 20 September 2010

Statements

EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors (English)
0 references
0 references
Mustafa Daghistani
Jamshid Sorouri Khorashad
Christos Paliompeis
Dragana Milojkovic
Valeria A De Melo

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit